{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T00:51:45Z","timestamp":1794617505306,"version":"4.9.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T00:00:00Z","timestamp":1765324800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T00:00:00Z","timestamp":1768262400000},"content-version":"vor","delay-in-days":34,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key R&D Program of China","doi-asserted-by":"crossref","award":["2024YFC2419400"],"award-info":[{"award-number":["2024YFC2419400"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U24A20758"],"award-info":[{"award-number":["U24A20758"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Beijing Natural Science Foundation","award":["L242062"],"award-info":[{"award-number":["L242062"]}]},{"name":"National High Level Hospital Clinical Research Funding","award":["2022-PUMCH-D-001, 2022-PUMCH-D-002, 2022-PUMCH-C-020, 2022-PUMCH-A-107"],"award-info":[{"award-number":["2022-PUMCH-D-001, 2022-PUMCH-D-002, 2022-PUMCH-C-020, 2022-PUMCH-A-107"]}]},{"name":"CAMS Innovation Fund for Medical Sciences","award":["2023-I2M-2-005, 2021-I2M-1-005"],"award-info":[{"award-number":["2023-I2M-2-005, 2021-I2M-1-005"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["EJNMMI Res"],"DOI":"10.1186\/s13550-025-01340-5","type":"journal-article","created":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T12:27:49Z","timestamp":1765369669000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["99mTc-Labeled FAPI SPECT and 18F-FDG PET imaging for visualization and evaluation of connective tissue disease-associated interstitial lung disease"],"prefix":"10.1186","volume":"16","author":[{"given":"Jingnan","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueyang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangzhong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangjie","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1216-083X","authenticated-orcid":false,"given":"Li","family":"Huo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,10]]},"reference":[{"key":"1340_CR1","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/s0140-6736(22)01052-2","volume":"400","author":"M Wijsenbeek","year":"2022","unstructured":"Wijsenbeek M, Suzuki A, Maher TM. Interstitial lung diseases. Lancet. 2022;400:769\u201386. https:\/\/doi.org\/10.1016\/s0140-6736(22)01052-2.","journal-title":"Lancet"},{"key":"1340_CR2","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1007\/s00408-020-00383-w","volume":"198","author":"N Jeganathan","year":"2020","unstructured":"Jeganathan N, Sathananthan M. Connective tissue disease-related interstitial lung disease: prevalence, patterns, predictors, prognosis, and treatment. Lung. 2020;198:735\u201359. https:\/\/doi.org\/10.1007\/s00408-020-00383-w.","journal-title":"Lung"},{"key":"1340_CR3","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1164\/rccm.202103-0559UP","volume":"203","author":"AJ Podolanczuk","year":"2021","unstructured":"Podolanczuk AJ, Wong AW, Saito S, Lasky JA, Ryerson CJ, Eickelberg O. Update in interstitial lung disease 2020. Am J Respir Crit Care Med. 2021;203:1343\u201352. https:\/\/doi.org\/10.1164\/rccm.202103-0559UP.","journal-title":"Am J Respir Crit Care Med"},{"key":"1340_CR4","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/j.resinv.2021.04.011","volume":"59","author":"Y Kondoh","year":"2021","unstructured":"Kondoh Y, Makino S, Ogura T, Suda T, Tomioka H, Amano H, et al. 2020 guide for the diagnosis and treatment of interstitial lung disease associated with connective tissue disease. Respir Investig. 2021;59:709\u201340. https:\/\/doi.org\/10.1016\/j.resinv.2021.04.011.","journal-title":"Respir Investig"},{"key":"1340_CR5","doi-asserted-by":"publisher","DOI":"10.1177\/1759720x211032457","volume":"13","author":"M Kuwana","year":"2021","unstructured":"Kuwana M, Gil-Vila A, Selva-O\u2019Callaghan A. Role of autoantibodies in the diagnosis and prognosis of interstitial lung disease in autoimmune rheumatic disorders. Ther Adv Musculoskelet Dis. 2021;13:1759720x211032457. https:\/\/doi.org\/10.1177\/1759720x211032457.","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"1340_CR6","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1164\/rccm.200412-1756OC","volume":"172","author":"DA Lynch","year":"2005","unstructured":"Lynch DA, Godwin JD, Safrin S, Starko KM, Hormel P, Brown KK, et al. High-resolution computed tomography in idiopathic pulmonary fibrosis: diagnosis and prognosis. Am J Respir Crit Care Med. 2005;172:488\u201393. https:\/\/doi.org\/10.1164\/rccm.200412-1756OC.","journal-title":"Am J Respir Crit Care Med"},{"key":"1340_CR7","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0210-2022","author":"GM Joy","year":"2023","unstructured":"Joy GM, Arbiv OA, Wong CK, Lok SD, Adderley NA, Dobosz KM, et al. Prevalence, imaging patterns and risk factors of interstitial lung disease in connective tissue disease: a systematic review and meta-analysis. Eur Respir Rev. 2023. https:\/\/doi.org\/10.1183\/16000617.0210-2022.","journal-title":"Eur Respir Rev"},{"key":"1340_CR8","doi-asserted-by":"publisher","DOI":"10.3390\/ph16101434","volume":"16","author":"Y Liu","year":"2023","unstructured":"Liu Y, Zhang Q, Zhang Y, Wang J, Wu Y, Yang G, et al. 99m)tc-labeled FAPI SPECT imaging in idiopathic pulmonary fibrosis: preliminary results. Pharmaceuticals (Basel, Switzerland). 2023;16:1434. https:\/\/doi.org\/10.3390\/ph16101434.","journal-title":"Pharmaceuticals (Basel, Switzerland)"},{"key":"1340_CR9","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1164\/ajrccm.161.2.ats3-00","volume":"161","author":"American Thoracic Society","year":"2000","unstructured":"American Thoracic Society. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American thoracic society (ATS), and the European respiratory society (ERS). Am J Respir Crit Care Med. 2000;161:646\u201364. https:\/\/doi.org\/10.1164\/ajrccm.161.2.ats3-00.","journal-title":"Am J Respir Crit Care Med"},{"key":"1340_CR10","doi-asserted-by":"crossref","unstructured":"Cheng L, Liu F, Gao L, Sun L, Hou Y, Liu Y. An Integrated Framework of Projection and Attenuation Correction for Quantitative SPECT\/CT Reconstruction. 2021 IEEE Nuclear Science Symposium and Medical Imaging Conference (NSS\/MIC): IEEE; 2021. pp. 1\u20133.","DOI":"10.1109\/NSS\/MIC44867.2021.9875924"},{"key":"1340_CR11","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1164\/rccm.200706-877OC","volume":"177","author":"NS Goh","year":"2008","unstructured":"Goh NS, Desai SR, Veeraraghavan S, Hansell DM, Copley SJ, Maher TM. Interstitial lung disease in systemic sclerosis: a simple staging system. Am J Respir Crit Care Med. 2008;177:1248\u201354. https:\/\/doi.org\/10.1164\/rccm.200706-877OC.","journal-title":"Am J Respir Crit Care Med"},{"key":"1340_CR12","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1056\/NEJMra2005230","volume":"383","author":"M Wijsenbeek","year":"2020","unstructured":"Wijsenbeek M, Cottin V. Spectrum of fibrotic lung diseases. N Engl J Med. 2020;383:958\u201368. https:\/\/doi.org\/10.1056\/NEJMra2005230.","journal-title":"N Engl J Med"},{"issue":"1","key":"1340_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/s12931-017-0556-3","volume":"18","author":"A Justet","year":"2017","unstructured":"Justet A, Laurent-Bellue A, Thabut G, Dieudonne A, Debray MP, Borie R. <article-title update=\"added\">[18F]FDG PET\/CT predicts progression-free survival in patients with idiopathic pulmonary fibrosis. Respir Res. 2017;18(1):74. https:\/\/doi.org\/10.1186\/s12931-017-0556-3.","journal-title":"Respir Res"},{"key":"1340_CR14","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1007\/s00259-017-3917-8","volume":"45","author":"T Win","year":"2018","unstructured":"Win T, Screaton NJ, Porter JC, Ganeshan B, Maher TM, Fraioli F. <article-title update=\"added\">Pulmonary 18F-FDG uptake helps refine current risk stratification in idiopathic pulmonary fibrosis (IPF). Eur J Nucl Med Mol Imaging. 2018;45:806\u201315. https:\/\/doi.org\/10.1007\/s00259-017-3917-8.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1340_CR15","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.ejphar.2017.05.022","volume":"809","author":"C Egger","year":"2017","unstructured":"Egger C, Cannet C, Gerard C, Suply T, Ksiazek I, Jarman E. Effects of the fibroblast activation protein inhibitor, PT100, in a murine model of pulmonary fibrosis. Eur J Pharmacol. 2017;809:64\u201372. https:\/\/doi.org\/10.1016\/j.ejphar.2017.05.022.","journal-title":"Eur J Pharmacol"},{"key":"1340_CR16","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1111\/j.1440-1843.2012.02272.x","volume":"18","author":"T Harada","year":"2013","unstructured":"Harada T, Watanabe K, Nabeshima K, Hamasaki M, Iwasaki H. Prognostic significance of fibroblastic foci in usual interstitial pneumonia and non-specific interstitial pneumonia. Respirology. 2013;18:278\u201383. https:\/\/doi.org\/10.1111\/j.1440-1843.2012.02272.x.","journal-title":"Respirology"},{"key":"1340_CR17","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.2967\/jnumed.124.268351","volume":"65","author":"M Hotta","year":"2024","unstructured":"Hotta M, Kim GHJ, Rerkpichaisuth V, Teng PY, Armstrong WR, Carlucci G, et al. Correlation of FAPI PET uptake with immunohistochemistry in explanted lungs from patients with advanced interstitial lung disease. J Nucl Med. 2024;65:1789\u201394. https:\/\/doi.org\/10.2967\/jnumed.124.268351.","journal-title":"J Nucl Med"},{"key":"1340_CR18","doi-asserted-by":"publisher","first-page":"502","DOI":"10.2967\/jnumed.124.267852","volume":"66","author":"MB Allison","year":"2025","unstructured":"Allison MB, Catana C, Zhou IY, Caravan P, Montesi SB. Molecular imaging of pulmonary fibrosis. J Nucl Med. 2025;66:502\u20135. https:\/\/doi.org\/10.2967\/jnumed.124.267852.","journal-title":"J Nucl Med"},{"key":"1340_CR19","doi-asserted-by":"publisher","first-page":"152","DOI":"10.2478\/rir-2024-0021","volume":"5","author":"MT Albu","year":"2024","unstructured":"Albu MT, Matei AE, Distler JHW, Giesel FL, Mori Y. Fibroblast activation protein inhibitor PET\/CT as an emerging diagnostic modality in interstitial lung disease and other fibrotic conditions. Rheumatol Immunol Res. 2024;5:152\u20136. https:\/\/doi.org\/10.2478\/rir-2024-0021.","journal-title":"Rheumatol Immunol Res"},{"key":"1340_CR20","doi-asserted-by":"publisher","first-page":"e17","DOI":"10.1097\/RLU.0000000000005505","volume":"50","author":"M Bahtouee","year":"2025","unstructured":"Bahtouee M, Jafari E, Khazaei M, Aram N, Amini A, Jokar N, et al. Exploring the potential value of [ 68 Ga]Ga-FAPI-46 PET\/CT for molecular assessment of fibroblast activation in interstitial lung disease: A Single-Center pilot study. Clin Nucl Med. 2025;50:e17\u201325. https:\/\/doi.org\/10.1097\/RLU.0000000000005505.","journal-title":"Clin Nucl Med"},{"key":"1340_CR21","doi-asserted-by":"publisher","first-page":"E185","DOI":"10.1016\/S2665-9913(20)30421-5","volume":"3","author":"C Bergmann","year":"2021","unstructured":"Bergmann C, J\u00f6rg HW, Treutlein C, M\u00fcller AT, Atzinger A, Matei AE, et al. 68Ga-FAPI-04 PET-CT for molecular assessment of fibroblast activation and risk evaluation in systemic sclerosis-associated interstitial lung disease: a single-centre, pilot study. Lancet Rheumatol. 2021;3:E185\u201394.","journal-title":"Lancet Rheumatol"},{"key":"1340_CR22","doi-asserted-by":"publisher","first-page":"102598","DOI":"10.1016\/j.eclinm.2024.102598","volume":"72","author":"K Kastrati","year":"2024","unstructured":"Kastrati K, Nakuz TS, Kulterer OC, Ge\u00dfl I, Simader E, Mrak D, et al. FAPi PET\/CT for assessment and visualisation of active myositis-related interstitial lung disease: a prospective observational pilot study. EClinMed. 2024;72:102598. https:\/\/doi.org\/10.1016\/j.eclinm.2024.102598.","journal-title":"EClinMed"},{"key":"1340_CR23","doi-asserted-by":"publisher","first-page":"127","DOI":"10.2967\/jnumed.121.261925","volume":"63","author":"M Rohrich","year":"2022","unstructured":"Rohrich M, Leitz D, Glatting FM, Wefers AK, Weinheimer O, Flechsig P, et al. Fibroblast activation protein-specific PET\/CT imaging in fibrotic interstitial lung diseases and lung cancer: a translational exploratory study. J Nucl Med. 2022;63:127\u201333. https:\/\/doi.org\/10.2967\/jnumed.121.261925.","journal-title":"J Nucl Med"},{"key":"1340_CR24","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1007\/s00259-023-06564-y","volume":"51","author":"Y Mori","year":"2024","unstructured":"Mori Y, Kramer V, Novruzov E, Mamlins E, R\u00f6hrich M, Fern\u00e1ndez R, et al. Initial results with [(18)F]FAPI-74 PET\/CT in idiopathic pulmonary fibrosis. Eur J Nucl Med Mol Imaging. 2024;51:1605\u201311. https:\/\/doi.org\/10.1007\/s00259-023-06564-y.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1340_CR25","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1164\/rccm.202110-2414OC","volume":"207","author":"P Yang","year":"2023","unstructured":"Yang P, Luo Q, Wang X, Fang Q, Fu Z, Li J, et al. Comprehensive analysis of fibroblast activation protein expression in interstitial lung diseases. Am J Respir Crit Care Med. 2023;207:160\u201372. https:\/\/doi.org\/10.1164\/rccm.202110-2414OC.","journal-title":"Am J Respir Crit Care Med"},{"issue":"Suppl 5","key":"1340_CR26","doi-asserted-by":"publisher","first-page":"v59","DOI":"10.1093\/rheumatology\/ken271","volume":"47","author":"AU Wells","year":"2008","unstructured":"Wells AU. High-resolution computed tomography and scleroderma lung disease. Rheumatology (Oxford). 2008;47(Suppl 5):v59\u201361. https:\/\/doi.org\/10.1093\/rheumatology\/ken271.","journal-title":"Rheumatology (Oxford)"}],"container-title":["EJNMMI Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13550-025-01340-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13550-025-01340-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13550-025-01340-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T04:56:04Z","timestamp":1768366564000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13550-025-01340-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,10]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1340"],"URL":"https:\/\/doi.org\/10.1186\/s13550-025-01340-5","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-6921334\/v1","asserted-by":"object"}]},"ISSN":["2191-219X"],"issn-type":[{"value":"2191-219X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,10]]},"assertion":[{"value":"26 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval was obtained by the Institutional Review Board of Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College (Ethics committee approval No. ZS-3038).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"9"}}